You just read:

A New Review Stresses that Non-Vitamin K Antagonist Oral Anticoagulants Can Reduce Atrial Fibrillation-Related Stroke With Significantly Reduced Cardiovascular and Bleeding Risks Compared With Warfarin

News provided by

touchNEUROLOGY.com

09 Jun, 2016, 12:30 BST